<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pediatric Anesthesia &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pediatric-anesthesia/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Jan 2026 08:16:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Pediatric Anesthesia &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>HR020602 and Propofol: Safety in Pediatric Anesthesia</title>
		<link>https://bioengineer.org/hr020602-and-propofol-safety-in-pediatric-anesthesia/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 17 Jan 2026 08:16:43 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[HR020602]]></category>
		<category><![CDATA[Multicenter Study]]></category>
		<category><![CDATA[Pediatric Anesthesia]]></category>
		<category><![CDATA[Phase 2 Trial]]></category>
		<category><![CDATA[Propofol]]></category>
		<guid isPermaLink="false">https://bioengineer.org/hr020602-and-propofol-safety-in-pediatric-anesthesia/</guid>

					<description><![CDATA[In the ever-evolving landscape of pediatric medicine, the quest for safe and effective anesthetic protocols remains a critical priority. A recent multicenter study delves into this vital subject, examining a novel agent, HR020602, and its combination with propofol in children undergoing general anesthesia. This innovative research, originating from a team led by Zou and including [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317722</post-id>	</item>
		<item>
		<title>MiR-483-5p: A Potential Biomarker for Pediatric Anesthesia Risks</title>
		<link>https://bioengineer.org/mir-483-5p-a-potential-biomarker-for-pediatric-anesthesia-risks/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 15 Jan 2026 13:31:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket (virgülle ayrılmış): `MiR-483-5p]]></category>
		<category><![CDATA[Pediatric Anesthesia]]></category>
		<category><![CDATA[perioperative care` **Seçimlerin Açıklaması:** 1. **MiR-483-5p:** Araştırmanın temel odağı olan spesifik mikroRNA. 2. **Pediatric anesthesia:** Ç]]></category>
		<category><![CDATA[respiratory adverse events]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mir-483-5p-a-potential-biomarker-for-pediatric-anesthesia-risks/</guid>

					<description><![CDATA[Recent research has unveiled a promising avenue in the arena of pediatric anesthesiology, hailing from a collaborative study by Zhao, Yan, Liu, and their associated researchers. The focus of their investigation revolves around MiR-483-5p, a microRNA that holds significant potential as a biomarker for perioperative respiratory adverse events in children subjected to general anesthesia. This [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317188</post-id>	</item>
		<item>
		<title>Dexmedetomidine May Reduce Pediatric Postoperative Delirium</title>
		<link>https://bioengineer.org/dexmedetomidine-may-reduce-pediatric-postoperative-delirium/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 06 Oct 2025 20:46:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Dexmedetomidine]]></category>
		<category><![CDATA[Pediatric Anesthesia]]></category>
		<category><![CDATA[Pediatric Orthopedic Surgery]]></category>
		<category><![CDATA[Pediatric Postoperative Delirium]]></category>
		<category><![CDATA[Postoperative Complications Prevention]]></category>
		<guid isPermaLink="false">https://bioengineer.org/dexmedetomidine-may-reduce-pediatric-postoperative-delirium/</guid>

					<description><![CDATA[In recent years, the medical community has increasingly recognized the importance of addressing postoperative delirium, particularly in vulnerable populations such as pediatric patients. A groundbreaking study conducted by Sun et al., published in BMC Pediatrics, delves into the efficacy of intraoperative dexmedetomidine administration as a preventive measure against postoperative delirium in children undergoing orthopedic surgery. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">276581</post-id>	</item>
	</channel>
</rss>
